Novartis Investigative Site

Hatsukaichi, Hiroshima 739-0402

0 studies enrolling now · 3 studies all time

What they study most

Asthma, Atherosclerosis, Non-alcoholic Steatohepatitis (NASH)

Studies at this site

• Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH) — Stopped early
• Dose Finding Study for QAW039 in Asthma — Completed
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed